"I was put into cardiac care immediately and had to stop working. I loved my job. That was the worst thing ever said to me – that I couldn’t work."
For heart transplant recipient and organ donation advocate Roxanne Watson, her battle with heart disease culminated in her inability to live a normal life – a reality that her and countless other patients with debilitating conditions are forced to accept every day. But after a heart transplant, Watson was able to return to doing the things she loved, thanks to advances in anti-rejection medicines which have enabled her to recover and continue to stay healthy.
To ensure that tomorrow’s patients can benefit from life-saving medicines, The Atlantic, in partnership with PhRMA’s GOBOLDLY campaign, convened thought leaders to discuss the policies needed to foster biopharmaceutical innovation while ensuring access and affordability for patients.